Latest News
Moleculin Biotech, Inc.
- Moleculin Biotech, Inc. Estimates – MUN:MOL
- MOLECULIN BIOTECH INC Income Statement – GETTEX:A42P30
- Enterprise value to EBITDA forward of MOLECULIN BIOTECH INC – GETTEX:A42P30
- Enterprise value to revenue forward of MOLECULIN BIOTECH INC – GETTEX:A42P30
- EBITDA margin % of MOLECULIN BIOTECH INC – GETTEX:A42P30
- MOLECULIN BIOTECH INC Earnings and Revenue – GETTEX:A42P30
- Return on invested capital % of MOLECULIN BIOTECH INC – GETTEX:A42P30
- After tax other income/expense of MOLECULIN BIOTECH INC – GETTEX:A42P30
- MOLECULIN BIOTECH INC Balance Sheet – GETTEX:A42P30
- MOLECULIN BIOTECH INC Financial Statements – GETTEX:A42P30
- Form 4 Moleculin Biotech Inc: Walter V. Klemp (Director, CEO and President) For: 15 October
- Moleculin Biotech completes Part A enrollment in MIRACLE; 89 patients, Q1 2027 readout on track
Headlines from the last 30 days, linking to the original publishers. See all market news →